HB Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Buy
58,212
+1,525
+3% +$82.8K 0.01% 421
2026
Q1
$3.56M Buy
56,687
+6,850
+14% +$548K 0.02% 314
2025
Q4
$4.75M Sell
49,837
-454
-0.9% -$44.5K 0.03% 254
2025
Q3
$4.91M Buy
50,291
+5,030
+11% +$521K 0.03% 255
2025
Q2
$4.86M Buy
45,261
+6,502
+17% +$658K 0.04% 234
2025
Q1
$3.91M Buy
38,759
+8,723
+29% +$878K 0.03% 264
2024
Q4
$2.68M Buy
30,036
+1,676
+6% +$148K 0.03% 240
2024
Q3
$2.38M Buy
28,360
+5,342
+23% +$421K 0.03% 252
2024
Q2
$1.77M Buy
23,018
+3,219
+16% +$236K 0.02% 281
2024
Q1
$1.36M Buy
19,799
+728
+4% +$46.8K 0.02% 305
2023
Q4
$1.1M Buy
19,071
+404
+2% +$21.6K 0.02% 303
2023
Q3
$986K Buy
18,667
+4,279
+30% +$224K 0.02% 296
2023
Q2
$778K Buy
14,388
+1,048
+8% +$54.7K 0.01% 330
2023
Q1
$667K Buy
13,340
+2,022
+18% +$95.3K 0.01% 356
2022
Q4
$524K Buy
11,318
+5,041
+80% +$218K 0.01% 385
2022
Q3
$243K Buy
+6,277
New +$252K 0.01% 487
2022
Q2
Sell
-7,161
Closed -$317K 584
2022
Q1
$317K Buy
+7,161
New +$310K 0.01% 438

Other funds holding BSX

HB Wealth Management's BSX Position: Q2 2026 in Review

HB Wealth Management increased its Boston Scientific (BSX) stake by 2.7% in Q2 2026, buying an estimated $82.8K and bringing the position to 58,212 shares worth $2.48M. The position accounts for 0.01% of the portfolio, ranked #421.

HB Wealth Management first reported a position in BSX in Q1 2022 and has held it in 17 quarters since. The position peaked at $4.91M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • HB Wealth Management held 58,212 shares of Boston Scientific worth $2.48M as of Q2 2026.
  • HB Wealth Management bought 1,525 Boston Scientific shares in Q2 2026, an estimated $82.8K.
  • Boston Scientific made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #421 holding.
  • HB Wealth Management first reported a position in Boston Scientific in Q1 2022 and has held it in 17 quarters since.
  • HB Wealth Management's Boston Scientific position peaked at $4.91M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.